|

FOLFIRINOX/mFOLFIRINOX Clinical Trials

1 actively recruiting trial across 1 location

No change since May 2026

Pipeline

Phase 1: 1

Top Sponsors

  • Innovent Biologics (Suzhou) Co. Ltd.1

Indications

  • Locally Advanced (Unresectable) or Metastatic Solid Tumors1
  • Cancer1

Austin, Texas1 trial

A First-in-human Study of IBI343 in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors

Next Oncology-Austin

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.